Tag

Tag: Argenx

argenx myasthenia gravis efgartigimod

29/05/2020 2 mins

Argenx Follows up Phase III Success with Giant €785M Global Offering

argenx antibody efgartigimod myastenia gravis

26/05/2020 2 mins

Argenx’s Rare Disease Treatment Strikes Gold in Phase III

argenx blood cancer autoimmune disease

11/11/2019 1 min

Argenx Raises Whopping €502M in Global Offering

argenx regenerative medicine agomAb llama-inspired antibodies

03/04/2019 2 mins

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

argenx llama-inspired antibodies cover cancer immunotherapy

05/12/2018 2 mins

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

29/10/2018 6 mins

The Billion-Euro European Biotech Companies in 2018

Argenx story - antibody drugs & fundraiser

19/09/2018 1 min

Argenx Attracts Huge €250M Investment Following Positive Phase II Trial

14/12/2017 1 min

Belgian Biotech Raises $231M to Continue Developing its Antibody Therapies

11/12/2017 1 min

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

23/08/2017 1 min

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

argenx blood cancer autoimmune disease

20/06/2017 1 min

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

22/05/2017 <1 min

UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.